Autres langues Cerus Corporation

Actions

CERS

US1570851014

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 25/04/2024			Varia. 5j.	Varia. 1 janv.
1,7 ^USD	+2,41 %		+3,66 %	-21,30 %

12/04	CERUS CORPORATION : Craig-Hallum favorable sur le dossier	ZM
26/03	Cerus Corporation annonce l'approbation par la FDA d'une durée de conservation prolongée pour les sets de traitement plaquettaire INTERCEPT - doublant ainsi la durée de conservation précédente	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Cerus Corporation to Release First Quarter 2024 Financial Results on May 2, 2024	18/04
Cerus Corporation Announces FDA Approval of Extended Shelf Life for INTERCEPT Platelet Processing Sets, Doubling Previous Shelf Life	27/03
Cerus Corporation Announces FDA Approval of Extended Shelf Life for INTERCEPT Platelet Processing Sets – Doubling Previous Shelf Life	26/03
Cerus Corporation Announces FDA Approval of Extended Shelf Life for INTERCEPT Platelet Processing Sets - Doubling Previous Shelf Life	26/03
Cerus Says Intercept Blood System Meets Non-Inferiority Goal in Phase 3 Study; Shares Rise	19/03
Cerus Shares Rise on Positive Results for Intercept Blood Cells Trial	19/03
Cerus Corporation Announces Positive Topline Results for the Phase 3 Clinical Trial of the INTERCEPT Blood System for Red Blood Cells in Cardiovascular Surgery Patients	19/03
Cerus Corporation Announces Positive Topline Results for the Phase 3 Clinical Trial of the INTERCEPT Blood System for Red Blood Cells in Cardiovascular Surgery Patients	19/03
Cerus Insider Sold Shares Worth $256,377, According to a Recent SEC Filing	15/03
Cerus: Q4 Earnings Snapshot	05/03
Cerus Reiterates Full Year 2024 Product Revenue Guidance of $172-$175 Million	05/03
Earnings Flash (CERS) CERUS CORPORATION Reports Q4 Revenue $53.3M, vs. Street Est of $52M	05/03
Cerus Corporation Announces Fourth Quarter and Full-Year 2023 Financial Results	05/03
Cerus Corporation Reiterates Product Revenue Guidance for the Full Year 2024	05/03
Cerus Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	05/03
Microsize Announces Expanded CDMO Relationship with Cerus Corporation	27/02
Cerus Corporation to Release Fourth Quarter and Full-Year 2023 Financial Results on March 5, 2024	20/02
Cerus Corporation to Participate in Upcoming Investor Conferences	01/02
Cerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2023 Product Revenue and Provides Business Update	08/01
Cerus Corporation Reports Unaudited Preliminary Revenue Results for the Fourth Quarter and Full-Year 2023	08/01

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Cerus Corporation

Actions

CERS

US1570851014

Autres langues

Filtres